Can big brands explore cannabis, & psychedelics without saying it out loud?

What happens when cannabis and natural compounds expertise, a global network, and AI-driven product strategy collide? David Traylor of Golden Eagle Partners introduces Skunk Works Nature AI. This new venture helps major consumer brands quietly explore cannabinoids and other natural compounds. Does a large beverage company want a CBG infused drink to help University Students get over their exam anxiety? Does a Fast-Moving Consumer Goods Brand want a toothpaste with CBN to help people sleep? Does a cosmetics company want a micro-dosed psychedelic lipstick for when an artist or CEO needs some creativity on demand? Large companies may be canna-curious but stigma still slows innovation. The confidential advice and expertise of Skunk Works Nature AI should bring serious players into the space. The future belongs to evidence-based product development built around cannabinoids, alkaloids, terpenes, and other natural compounds.

David also discusses the capital crunch in cannabis, why so many firms have exited the sector, and a fascinating discussion about cannabis language and policy, including David’s clearer framework of THC-plus and THC-minus.

Listen now to learn how investors, scientists, and global brands are preparing for the next phase of cannabis, psychedelics, and functional natural products.

David Traylor - LinkedIn

Skunk Works Nature AI - website

Transcripts, papers and so much more at: reefermed.ca